# Nine Square Therapeutics Corp — Form D/A

Nine Square Therapeutics Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2021-02-03. The offering totals $50.0M, of which $4.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-02-03
- Form: D/A
- Accession: 0001816518-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $4.2M
- Remaining: $45.8M
- Investors: 1
- Date of first sale: 2020-06-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-370079

## Issuer

- Name: Nine Square Therapeutics Corp
- CIK: 0001816518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 230 PARK AVENUE, SUITE 2800, NEW YORK, NY, 10169
- Phone: 781-367-5419

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Michael Ehlers | Director | Morristown, NJ |
| Seth Harrison | Director | Redwood City, CA |
| Matthew Jacobson | Director | South San Francisco, CA |
| Spiros Liras | Director | New York, NY |
| Spiros Liras | Executive Officer | New York, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-07-01](https://search.stillhousedata.com/formd/0001816518-20-000001) | D | $50.0M | $1.0M |

## More

- [CIK 1816518 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1816518&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001816518-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.